Navigation Links
BiOptix Announces Fall 2012 Tradeshow and Symposia Schedule
Date:8/22/2012

BOULDER, Colo., Aug. 22, 2012 /PRNewswire/ -- BiOptix today officially announced its fall 2012 Tradeshow and Symposia schedule.  These events will highlight the BiOptix Enhanced Surface Plasmon Resonance (ESPR) technology and the forthcoming BiOptix 404pi, a novel and game-changing label-free SPR instrument for kinetic detection. BiOptix Events for fall 2012 include:

  • 34th Semiannual Biotechnology Symposia, University of California, San Diego:  August 23rd
  • HUPO – 11th Annual World Congress:  September 9 – 13th
  • BioWest 2012:   September 11th
  • MipTec:  September 25 – 27th
  • NIH Research Festival:  October 11 – 12th
  • AAPS–American Association of Pharmaceutical Scientists:  October 14 – 17th
  • 22nd Annual Bristol-Myers Squibb R&D Symposium:  October 29 – 30th
  • Label-Free Technologies–Advances and Applications:   November 1 – 3rd
  • 4th Annual PEGS-Europe Conference:  November 6 – 8th
  • Antibody Engineering–23rd Annual International Conference:   December 2 – 6th

(Logo: http://photos.prnewswire.com/prnh/20120822/LA61037LOGO)

"BiOptix is excited to be represented at and participate in some of the most prestigious scientific events in Europe and North America for the balance of 2012," noted Ken Wilczek, Vice President of Sales and Marketing for BiOptix. "2012 has been groundbreaking for BiOptix, as we have met with and presented our unique SPR technology to over 3,000 scientific researchers so far. We are enthusiastic t
'/>"/>

SOURCE BiOptix
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Interventional Spine Announces its 75th Patient Treated with the PerX360 Percutaneous Spinal Fusion Technology
2. Precision Automation Expert DWFritz Automation Announces Website Launch www.DWFritz.com
3. CPhI South America Expands Offering for 2013, Announces Co-Location with Food Ingredients South America
4. EFJohnson Announces Impact Partner Dealer Program
5. Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract
6. Kallo Announces Purchase Order For Its Specialist EMR - EMCURx
7. CryoLife Announces Initiation of Quarterly Cash Dividend
8. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
9. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
10. Angeion Announces Name Change and New Trading Symbol Effective Tuesday, August 21, 2012
11. VWR Funding, Inc. Announces Proposed Offering Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... HAMBURG, Germany , Aug. 21, 2014  IBM (NYSE: ... Deutsches Elektronen-Synchrotron ( DESY ), a leading national research ... up management and storage of massive volumes of x-ray ... architecture based on IBM software defined technology can handle ... peak performance and help scientists worldwide gain faster insights ...
(Date:8/21/2014)... -- Zacks.com announces the list of stocks featured in the Analyst ... latest news and events impacting stocks and the financial markets. ... HPQ - Free Report ), IBM (NYSE: IBM - ... Free Report ), GlaxoSmithKline plc (NYSE: GSK - Free ... Free Report ). Today, Zacks is promoting its ...
(Date:8/21/2014)... Aug. 21, 2014  Henry Schein, Inc. (NASDAQ: ... and services to office-based dental, animal health and medical practitioners, ... conferences in September: , September 4, 2014 – ... , NY at 12:50 p.m. ET , September 8, 2014 ... New York , NY at 1:25 p.m. ET ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11Henry Schein To Present At Two Investor Conferences In September 2
... InCode BioPharmaceutics, Inc.,an emerging biopharmaceutical company, today ... their lead drug candidate rC3-1 for,the treatment ... nocturnal,hemoglobinuria (PNH). The complete results will be ... Basel, Switzerland, September 28,2008., The only ...
... a leading innovator,of physiological monitoring solutions for more ... with its breakthrough technology to measure,regional oxygen saturation. ... continuous monitoring of the regional blood oxygenation,in the ... and outcomes from an ongoing clinical study at ...
Cached Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2
(Date:8/21/2014)... mothers are less likely than white moms to breast-feed ... in neighborhoods with many black residents do less to ... residents, a U.S. government study finds. Key practices ... centers where the black population is higher than average, ... Prevention reported Thursday. These practices include efforts to ...
(Date:8/21/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- Among seniors, ... suggests. The study involved more than 2,500 people, aged ... the study and again two, six and eight years later. ... in the person,s risk of death during the study period, ... and effect, researchers led by Sharon Christ of Purdue University ...
(Date:8/21/2014)... York, New York (PRWEB) August 21, 2014 ... filed against C.R. Bard, Inc. continue to move ... U.S. District Court, Southern District of West Virginia, ... Order issued on August 14th, the Court has ... evidence that requires special handling, division, storage and ...
(Date:8/21/2014)... to focus on her body in terms of how ... as a complete human being with thoughts and feelings. ... the media, how does it affect individual romantic relationships? ... , a SAGE journal, finds that more objectification of ... of sexual pressure and coercion., Researchers Laura R. Ramsey ...
(Date:8/21/2014)... FL (PRWEB) August 21, 2014 The ... published today in The Journal of the American Medical ... more invasive cancers and reduces unnecessary recalls. Memorial Healthcare ... in the study. , “This study confirms what we ... invasive, harmful cancers we want to find and, at ...
Breaking Medicine News(10 mins):Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3Health News:Objectification in romantic relationships related to sexual pressure and coercion 2Health News:Dr. Mary Hayes: Study Shows 3D Mammography Finds More Invasive Cancers While Reducing Unnecessary Recalls 2
... Citizens by Enhancing Their ... Own Plans, ... help them prepare for one of the most daunting public,health emergencies: an ... Policy (CIDRAP) at,the University of Minnesota and the Pew Center on the ...
... Organization Urges Consumers to ... Beware!, ... Society of Cosmetic Dermatology and Aesthetic,Surgery (ASCDAS), responded to the recent decision ... of Healing Arts to ban the,liposuction treatment, Lipodissolve. "This procedure is still ...
... or circulating tumour cells (CTCs), are known to be associated ... Now, for the first time, a group of scientists have ... chemotherapy treatment and hence may be able to identify those ... such treatment in future. , Dr. Julia Jckstock, from the ...
... Driven by Launches, of Disease-Modifying Therapies, According to a New ... ... Resources, WALTHAM, Mass., Sept. 24 Decision Resources, one of ... that by 2016 Genentech/Roche,s Lucentis and Eli,Lilly,s ruboxistaurin will drive the ...
... DUBLIN, Ohio, Sept. 24 Cardinal Health, a,global provider ... of health care, today announced President and Chief Executive,Officer ... effective Nov. 8,following the company,s 2007 annual shareholder meeting. ... who plans to retire,at the end of the company,s ...
... University of Warwick, and University College London, have found that ... death from cardiovascular disease. However they have also found that ... double the risk of death. , In research to be ... Society, Professor Francesco Cappuccio from the University of Warwicks Warwick ...
Cached Medicine News:Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 2Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 3Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 4Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 5Health News:Lipodissolve - Is it Safe??? 2Health News:Cancer cells in blood can identify risk of recurrence in breast cancer 2Health News:Cancer cells in blood can identify risk of recurrence in breast cancer 3Health News:Genentech/Roche's Lucentis and Eli Lilly's Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets 2Health News:Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years 2Health News:Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years 3Health News:Researchers say lack of sleep doubles risk of death... but so can too much sleep 2
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri...
... Scrub Care povidone-iodine (PVP-I) antimicrobial solutions ... control in all hospital and health-care settings. ... gel have a broad spectrum of activity, ... bacteria that may cause infection. The new ...
... hand sanitizers like Aplicare No Rinse Isopropyl ... as the recommended product for hand disinfection ... Guidelines for hand hygiene., According to the ... be prevented with better infection control programs. ...
This is long known for its purity and mildness, Castile Soap is also an effective cleaning agent that is used in a variety of applications. It rinses clean while leaving the skin soft and healthy....
Medicine Products: